34 results
6-K
MREO
Mereo Biopharma Group Plc
3 Sep 19
Current report (foreign)
4:05pm
, responsibilities and authority of an executive serving in such a position, subject to the oversight and direction of the Company’s chief executive
DEF 14A
MREO
Mereo Biopharma Group Plc
24 Apr 24
Definitive proxy
7:30am
the Chairman can focus on leading the Board in its fundamental role of providing advice to and independent oversight of management. Specifically, the Chair … director due to her employment as Chief Executive Officer of the Company.
Board Oversight of Risk Management
Our management is primarily responsible
F-4
EX-10.8
MREO
Mereo Biopharma Group Plc
25 Jan 19
Registration of securities (foreign)
12:00am
and senior management oversight and compliance with legal obligations and corporate policies; and
act as a liaison from time to time with the relevant
20-F
2018 FY
EX-4.19
MREO
Mereo Biopharma Group Plc
29 Apr 19
Annual report (foreign)
4:59pm
to any governmental agency or self-regulatory organization with oversight responsibility for the Company, or making other disclosures that are protected
10-K
6cibt
27 Mar 24
Annual report
5:20pm
20-F
yyxo fifv1d365de
29 Apr 19
Annual report (foreign)
4:59pm
6-K
EX-10.1
fh0a07cx2k0ng2ux6
3 Sep 19
Current report (foreign)
4:05pm
F-1/A
2fm3ta0bg mktxb9
12 Mar 20
Registration statement (foreign) (amended)
5:15pm
F-1/A
d2hxw
6 Mar 20
Registration statement (foreign) (amended)
5:32pm
F-4
EX-10.3
9k7pn1qt80esx
25 Jan 19
Registration of securities (foreign)
12:00am
424B5
laofi
23 Oct 20
Prospectus supplement for primary offering
4:40pm
F-3
m6uxermaj7b8f1
6 Oct 20
Shelf registration (foreign)
4:25pm
F-4/A
gumnltsp
15 Mar 19
Registration of securities (foreign) (amended)
5:08pm
424B3
cy24rsfpj3h68ju3lon
20 Mar 19
Prospectus supplement
4:58pm
F-4
nfjgv4tkm6032 xpc0de
25 Jan 19
Registration of securities (foreign)
12:00am